Azevan Pharmaceuticals logo — Innovative therapies for stress, mood, and behavior disorder...

Azevan Pharmaceuticals

Innovative therapies for stress, mood, and behavior disorders

Founded 1999 5 employees Series Unknown Total: $2.21M Biotechnology, Health Care +2

General Information

Company Name Azevan Pharmaceuticals
Founded Year 1999
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series Unknown
Social

Get notified when Azevan Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Azevan Pharmaceuticals

Azevan Pharmaceuticals is a clinical stage company focused on developing small molecule drugs to treat disorders related to stress, mood, and behavior. With a dedication to inhibiting the effects of arginine vasopressin, a peptide neurohormone associated with conditions such as major depression, intermittent explosive disorder, impulse control and anger disorders, as well as post-traumatic stress disorder (PTSD), the company aims to address unmet needs in mental health. Their product offerings, SRX251 and SRX246, are CNS-penetrating V1a receptor antagonists designed for oral administration, targeting stress-related CNS disorders including depression, PTSD, and intermittent explosive disorders. Formerly known as Serenix Pharmaceuticals, LLC, the company rebranded to Azevan Pharmaceuticals, Inc. in January 2002 and was founded in 1999. The company secured a $2.21M Venture Round investment on 18 October 2013 to further its innovative therapies. Headquartered in Bethlehem, Pennsylvania, Azevan Pharmaceuticals operates within the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy: pharmaceuticals, drug development, clinical stage, neurohormone, mood disorders, behavior disorders, small molecule drugs, arginine vasopressin, depression treatment, PTSD treatment, stress-related disorders, CNS-penetrating antagonists, mental health, bioavailability, Bethlehem, Pennsylvania

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 18 Oct 2013

Azevan Pharmaceuticals Alternatives & Competitors

Azevan Pharmaceuticals vs
The Ranch TN
The Ranch TN United States

The Ranch provides a highly effective, one-of-a-kind recovery experience for men and women strugglin...

31 employees
Care Economy, Health Care
Azevan Pharmaceuticals vs

Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS disorders with advan...

Debt Financing
Biotechnology, Health Care
Azevan Pharmaceuticals vs

A specialty practice using science and expertise to treat OCD and other anxiety disorders for client...

14 employees
Health Care, Health and Wellness

FAQ About Azevan Pharmaceuticals

Innovative therapies for stress, mood, and behavior disorders
Azevan Pharmaceuticals was founded in 1999.
Azevan Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Azevan Pharmaceuticals has approximately 5 employees.
Azevan Pharmaceuticals has completed 1 funding round, raising a total of $2.21M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Azevan Pharmaceuticals include The Ranch TN, BrainCells, Stress and Anxiety Services of NJ, LLC, Serenity Healthcare, Oaktree Connect . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Azevan Pharmaceuticals and The Ranch TN are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Azevan Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy